-
公开(公告)号:US11826572B2
公开(公告)日:2023-11-28
申请号:US17330883
申请日:2021-05-26
Inventor: Changfeng Tai
CPC classification number: A61N1/36164 , A61N1/0551 , A61N1/36062 , A61N1/36071 , A61N1/36153 , A61N1/36157
Abstract: A method of blocking a nerve or neuron by applying an electrical stimulation to the nerve or neuron, wherein the electrical stimulation is of an intensity below the excitation threshold of the nerve or neuron for a length of time sufficient to produce a block of nerve conduction or neuron excitation.
-
公开(公告)号:US20230365457A1
公开(公告)日:2023-11-16
申请号:US18225825
申请日:2023-07-25
Inventor: SAJAD HAGHANIFAR , BRADLEY D. PAFCHEK , PAUL W. LEU , TONGCHUAN GAO
CPC classification number: C03C15/00 , C03C17/06 , C03C17/30 , C03C2217/76 , B82Y30/00 , C03C2217/77 , C03C2217/75 , B82Y40/00
Abstract: The invention relates generally to optically high transparency and high haze structures and, more particularly, to plastic, e.g., polymer, and glass structures having a sub-wavelength texture formed on a surface thereof, which is effective to impart the optical properties of high transparency and high haze to the structures. The texture is in a grass-like or needle-like form. Additionally, the optically high transparency and high haze structures may include a transparent conductor. Furthermore, the glass structures may exhibit a self-cleaning function.
-
83.
公开(公告)号:US20230364301A1
公开(公告)日:2023-11-16
申请号:US18044969
申请日:2021-04-30
Inventor: Stephen Francis Badylak , George S. Hussey
CPC classification number: A61L27/3633 , A61L27/52 , A61L27/54 , A61L2400/06 , A61L2430/34
Abstract: A method is disclosed for treating a fistula in a subject, such as, but not limited to, an anal fistula. In some embodiments, the method includes administering locally to the fistula in the subject an effective amount of a composition comprising a mammalian acoustic extracellular matrix (ECM) hydrogel, and optionally trehalose. Compositions of use in these methods are also disclosed.
-
公开(公告)号:US20230348557A1
公开(公告)日:2023-11-02
申请号:US17795573
申请日:2021-02-05
Inventor: Udai Shankar Kammula , Ghanshyam Singh Yadav , Chetana Bhaskarla
IPC: C07K14/725 , C12N5/0783 , C12N15/86 , A61P35/00
CPC classification number: C07K14/7051 , C12N5/0636 , C12N15/86 , A61P35/00
Abstract: This document provides isolated immune cells that include an exogenous T cell receptor (TCR) having affinity for an Ataxia-Telangiesctasia Mutated (ATM) peptide, an exogenous TCR having affinity for an AT-rich interactive domain-containing protein 1A (ARID1A) peptide, or both an exogenous TCR having affinity for an ATM peptide and an exogenous TCR having affinity for an ARID1A peptide, as well as methods and materials for making such immune cells. For example, isolated immune cells that included an exogenous TCR having affinity for a mutant ATM and/or exogenous TCR having affinity for an ARID1A peptide, methods and materials for making such immune cells, and methods and materials for using such immune cells to treat mammals (e.g., a human having cancer) are provided.
-
公开(公告)号:US11802313B2
公开(公告)日:2023-10-31
申请号:US17227186
申请日:2021-04-09
Inventor: Laurie H. Andolina , John T. Greenamyre , Sruti Shiva
IPC: C12Q1/68 , C12Q1/6883 , C12Q1/686
CPC classification number: C12Q1/6883 , C12Q1/686 , C12Q2561/113 , C12Q2563/173 , C12Q2600/106 , C12Q1/686 , C12Q2561/113 , C12Q2563/173
Abstract: Methods are disclosed for detecting peripheral mitochondrial DNA damage and dysfunction. Methods are also disclosed that utilize blood samples to detect a neurodegenerative disease, such as Parkinson's disease, and determine the efficacy of therapy.
-
86.
公开(公告)号:US11793961B2
公开(公告)日:2023-10-24
申请号:US16341123
申请日:2017-10-18
Inventor: Youngjae Chun , Philip Charles Carullo
CPC classification number: A61M16/0409 , A61M16/0463 , A61M16/0488 , A61B17/1204 , A61B17/12104 , A61M25/0074 , A61M2202/0403 , A61M2205/0266 , A61M2210/105 , A61M2210/1053
Abstract: A temporary esophagus occlusion device for providing temporary occlusion of the esophagus during intubation of a in patient includes a frame configured to transition between a contracted state, in which it can be swallowed by the patient, and an expanded state, wherein in the expanded state, the frame has a maximum outer diameter sufficient to span an inner diameter of the esophagus of the patient. The device also includes a flexible cover connected to and extending over at least a portion of the frame when the frame is in the expanded state to at least partially block flow of fluid and/or solid materials through the esophagus and a guidewire attached to the frame, sized to be swallowed by the patient along with the frame and having a proximal end portion configured to remain external to the patient's body and a distal end connected to the frame.
-
公开(公告)号:US11782210B2
公开(公告)日:2023-10-10
申请号:US17658334
申请日:2022-04-07
Inventor: Paul Richard Ohodnicki, Jr. , Jung-Kun Lee , Yulin Liu , Ruishu Wright , Fei Lu , Jeffrey Wuenschell
CPC classification number: G02B6/132 , G02B2006/12035 , G02B2006/12138
Abstract: A method of making an optical fiber-based sensor includes providing an optical fiber, and providing a sensing or protection layer on a surface of the optical fiber by an atomic layer deposition (ALD) process.
-
88.
公开(公告)号:US11771555B2
公开(公告)日:2023-10-03
申请号:US16777007
申请日:2020-01-30
Inventor: Vinay Badhwar , Young Jae Chun , Antonio D'Amore , David S. Schwartzman , William R. Wagner
CPC classification number: A61F2/2418 , A61F2/243 , A61F2/2409 , A61F2/2412 , A61L27/14 , A61L27/50 , A61M25/09 , A61N1/3629 , A61F2002/9505 , A61F2210/0019 , A61F2240/001 , A61F2250/001 , A61F2250/0059 , A61L2400/16
Abstract: An atrioventricular prosthesis device is provided. The device includes a frame at least partially defining and enclosing a central cavity, the frame having a distal portion, a proximal portion, and a middle portion connected therebetween. The device further includes a valve construct formed, at least in part, from a cell growth scaffold, at least partially disposed within the central cavity defined by the frame. The valve construct includes: an annular portion defining an aperture and being connected to the frame for positioning the valve construct within the central cavity of the frame, and a plurality of leaflets extending longitudinally and radially inward from the annular portion. The frame and valve construct are transitionable to a deployed state, in which a diameter of at least a portion of the frame and the valve construct substantially conform to a diameter of a tricuspid and/or mitral valve opening.
-
89.
公开(公告)号:US20230285731A1
公开(公告)日:2023-09-14
申请号:US18141310
申请日:2023-04-28
Inventor: Louis D. Falo , Geza Erdos
IPC: A61M37/00
CPC classification number: A61M37/0015 , A61K9/0021
Abstract: A method of forming a microneedle array can include forming a microneedle array that has one or more bioactive component. The microneedle array can include a base portion and plurality of microneedles extending from the base portion, and the one or more bioactive components can be combined with other components to exhibit specific release kinetics when the microneedle array is inserted into the skin of a patient.
-
公开(公告)号:US11747342B2
公开(公告)日:2023-09-05
申请号:US17177612
申请日:2021-02-17
Inventor: John A. Kellum , Zhiyun Cao , Derek Angus , Sachin Purushottam Yende , Rena Angilena Sowell Robinson
IPC: G01N33/68
CPC classification number: G01N33/6848 , G01N2800/26
Abstract: A proteomic expression platform to identify age-related sepsis risk is disclosed using patients with an intra-abdominal infection. A semi-quantitative plasma proteomics workflow was applied which incorporated tandem immuno affinity depletion, iTRAQ labeling, strong cation exchange fractionation, and nanoflow-liquid chromatography coupled to high resolution mass spectrometry. A protein profile was determined that exhibit statistically significant differences in expression levels amongst patients with severe sepsis as a function of age. Representative pathways that are differentially-expressed include, but are not limited to, acute phase response, coagulation signaling, atherosclerosis signaling, lipid metabolism, and production of nitric oxide/reactive oxygen species.
-
-
-
-
-
-
-
-
-